Investors-Financial Information

Material Information

Material Information Announcement

Click on the Market Observation Post System for public information, where you can search for significant information by year/month. Please enter the code 6782 for Visco Vision Inc. on the page linked.

SEQ_NO 1
Date of announcement 2025/05/28
Time of announcement 13:58:25
To which item it meets paragraph 21
Date of events 2025/05/28
Subject To announce the proposal to dismiss prohibition of directors and their representatives to engage in competitive businesses.
Statement
  1. Date of the shareholders meeting resolution:2025/05/28
  2. Name and title of the director with permission to engage in competitive conduct:
    Director:Chung-I Lee
    Independent Director:Chiu-Jui Wei
  3. Items of competitive conduct in which the director is permitted to engage:
    (1)Director:Chung-I Lee Corporate Director Representative, Crystalvue Medical Corp.
    (2)Independent Director:Chiu-Jui Wei Independent Director, Continental Holdings Corp.
  4. Period of permission to engage in the competitive conduct:During the term as a director of Visco Vision.
  5. Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):Under Article 209 of the Company Act, the resolution is approved by the Company's Annual General Shareholders' Meeting on 2025/05/28.
  6. If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors (if it is not the operator of a Mainland-area enterprise, please enter “N/A” below):N/A
  7. Company name of the mainland China area enterprise and the director's position in the enterprise:N/A
  8. Address of the mainland China area enterprise:N/A
  9. Operations of the mainland China area enterprise:N/A
  10. Impact on the company's finance and business:N/A
  11. If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:N/A
  12. Any other matters that need to be specified:N/A